CTCF Regulates Growth and Erythroid Differentiation of Human Myeloid Leukemia Cells*

CTCF is a transcription factor and a candidate tumor suppressor that contains a DNA-binding domain composed of 11 zinc fingers. We reported previously that CTCF is differentially regulated during differentiation of human myeloid leukemia cells. In this study we aimed to investigate the role of CTCF in myeloid cell differentiation. A human cell line, K562, that can be chemically induced to differentiate into various hematopoietic lineages was chosen as a model system for this study. Several K562 cell lines with constitutive and conditional expression of CTCF have been generated. By using these model systems we demonstrated that: (i) ectopic expression of CTCF in K562 cells led to growth retardation and promotion of differentiation into the erythroid lineage; (ii) CTCF knock-down significantly inhibited differentiation of K562 cells into erythroid lineage; (iii) differentiation of K562 into the megakaryocytic lineage was not significantly affected; and (iv) down-regulation of MYC has been identified as one of the mechanisms by which CTCF promotes erythroid differentiation. Taken together our results demonstrate that CTCF is involved in the control of myeloid cell growth and differentiation.

[1]  A. Mackay,et al.  Heightened expression of CTCF in breast cancer cells is associated with resistance to apoptosis. , 2005, Cancer research.

[2]  J. Sedivy,et al.  p21Cip1 and p27Kip1 Induce Distinct Cell Cycle Effects and Differentiation Programs in Myeloid Leukemia Cells* , 2005, Journal of Biological Chemistry.

[3]  E. Klenova,et al.  Regulation of the transcription factor, CTCF, by phosphorylation with protein kinase CK2 , 2005, FEBS letters.

[4]  M. Lerman,et al.  Transcriptional regulator CTCF controls human interleukin 1 receptor-associated kinase 2 promoter. , 2005, Journal of molecular biology.

[5]  R. Ohlsson,et al.  Poly(ADP-ribosyl)ation and Epigenetics: Is CTCF PARt of the Plot? , 2005, Cell cycle.

[6]  Rolf Ohlsson,et al.  Poly(ADP-ribosyl)ation regulates CTCF-dependent chromatin insulation , 2004, Nature Genetics.

[7]  I. Ellis,et al.  Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1 , 2004, British Journal of Cancer.

[8]  Rolf Ohlsson,et al.  The binding sites for the chromatin insulator protein CTCF map to DNA methylation-free domains genome-wide. , 2004, Genome research.

[9]  R. Lotan,et al.  Hypermethylation and Silencing of the Putative Tumor Suppressor Tazarotene-Induced Gene 1 in Human Cancers , 2004, Cancer Research.

[10]  R. Renkawitz,et al.  Dynamic association of the mammalian insulator protein CTCF with centrosomes and the midbody. , 2004, Experimental cell research.

[11]  G. Felsenfeld,et al.  Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9 , 2004, The EMBO journal.

[12]  E. Rubio,et al.  Thec-myc Insulator Element and Matrix Attachment Regions Definethe c-myc ChromosomalDomain , 2003, Molecular and Cellular Biology.

[13]  J. Davie,et al.  The many roles of the transcriptional regulator CTCF. , 2003, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[14]  Victor V Lobanenkov,et al.  Thyroid hormone‐regulated enhancer blocking: cooperation of CTCF and thyroid hormone receptor , 2003, The EMBO journal.

[15]  Victor V Lobanenkov,et al.  CTCF functions as a critical regulator of cell-cycle arrest and death after ligation of the B cell receptor on immature B cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Victor V Lobanenkov,et al.  The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer. , 2002, Seminars in cancer biology.

[17]  B. Tycko,et al.  Chromosome arm 16q in Wilms tumors: Unbalanced chromosomal translocations, loss of heterozygosity, and assessment of the CTCF gene , 2002, Genes, chromosomes & cancer.

[18]  V. Saha,et al.  Chromatin Modification, Leukaemia and Implications for Therapy , 2002, British journal of haematology.

[19]  David A Jones,et al.  Reactivating the expression of methylation silenced genes in human cancer , 2002, Oncogene.

[20]  H. Soreq,et al.  Transcriptional regulation of erythropoiesis. Fine tuning of combinatorial multi-domain elements. , 2002, European journal of biochemistry.

[21]  A. West,et al.  Conserved CTCF Insulator Elements Flank the Mouse and Human β-Globin Loci , 2002, Molecular and Cellular Biology.

[22]  S. Orkin,et al.  Transcriptional regulation of erythropoiesis: an affair involving multiple partners , 2002, Oncogene.

[23]  S. Elgin,et al.  Epigenetic Codes for Heterochromatin Formation and Silencing Rounding up the Usual Suspects , 2002, Cell.

[24]  A. Feinberg,et al.  Tumor-associated zinc finger mutations in the CTCF transcription factor selectively alter tts DNA-binding specificity. , 2002, Cancer research.

[25]  Jeannie T. Lee,et al.  CTCF, a Candidate Trans-Acting Factor for X-Inactivation Choice , 2001, Science.

[26]  R Ohlsson,et al.  CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. , 2001, Trends in genetics : TIG.

[27]  P. Neiman,et al.  Cell growth inhibition by the multifunctional multivalent zinc-finger factor CTCF. , 2001, Cancer research.

[28]  S. Tapscott,et al.  CTCF-binding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus , 2001, Nature Genetics.

[29]  E. Lam,et al.  The influence of INK4 proteins on growth and self-renewal kinetics of hematopoietic progenitor cells. , 2001, Blood.

[30]  P. Neiman,et al.  Functional Phosphorylation Sites in the C-Terminal Region of the Multivalent Multifunctional Transcriptional Factor CTCF , 2001, Molecular and Cellular Biology.

[31]  H. Drexler,et al.  Continuous hematopoietic cell lines as model systems for leukemia-lymphoma research. , 2000, Leukemia research.

[32]  Javier León,et al.  c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells , 2000, Oncogene.

[33]  M. Berridge,et al.  Superoxide produced by activated neutrophils efficiently reduces the tetrazolium salt, WST-1 to produce a soluble formazan: a simple colorimetric assay for measuring respiratory burst activation and for screening anti-inflammatory agents. , 2000, Journal of immunological methods.

[34]  P. Crespo,et al.  H-, K- and N-Ras inhibit myeloid leukemia cell proliferation by a p21WAF1-dependent mechanism , 2000, Oncogene.

[35]  P. Ponka.  Cell Biology of Heme , 1999 .

[36]  P. Crespo,et al.  Regulation of c-Myc and Max in megakaryocytic and monocytic-macrophagic differentiation of K562 cells induced by protein kinase C modifiers: c-Myc is down-regulated but does not inhibit differentiation. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[37]  A. West,et al.  The Protein CTCF Is Required for the Enhancer Blocking Activity of Vertebrate Insulators , 1999, Cell.

[38]  Sun-Hee Kim,et al.  Role of Ras/ERK-dependent pathway in the erythroid differentiation of K562 cells , 1999, Experimental & Molecular Medicine.

[39]  C. Strathdee,et al.  Efficient control of tetracycline-responsive gene expression from an autoregulated bi-directional expression vector. , 1999, Gene.

[40]  A. Bigas,et al.  Differential expression and phosphorylation of CTCF, a c‐myc transcriptional regulator, during differentiation of human myeloid cells , 1999, FEBS letters.

[41]  P. Neiman,et al.  A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers , 1998, Genes, chromosomes & cancer.

[42]  J. Bieker.  Erythroid‐specific transcription , 1998, Current opinion in hematology.

[43]  A. Vostrov,et al.  The zinc finger protein CTCF binds to the APBbeta domain of the amyloid beta-protein precursor promoter. Evidence for a role in transcriptional activation. , 1997, The Journal of biological chemistry.

[44]  C. Dang,et al.  Max and inhibitory c-Myc mutants induce erythroid differentiation and resistance to apoptosis in human myeloid leukemia cells , 1997, Oncogene.

[45]  Victor V Lobanenkov,et al.  Negative protein 1, which is required for function of the chicken lysozyme gene silencer in conjunction with hormone receptors, is identical to the multivalent zinc finger repressor CTCF , 1997, Molecular and cellular biology.

[46]  E. Whitelaw,et al.  Variegated expression of a globin transgene correlates with chromatin accessibility but not methylation status. , 1996, Nucleic acids research.

[47]  P. Neiman,et al.  An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes , 1996, Molecular and cellular biology.

[48]  J. León,et al.  Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells. , 1995, Oncogene.

[49]  P. Neiman,et al.  CTCF, a conserved nuclear factor required for optimal transcriptional activity of the chicken c-myc gene, is an 11-Zn-finger protein differentially expressed in multiple forms , 1993, Molecular and cellular biology.

[50]  P. Crespo,et al.  Down-regulation of c-myc gene is not obligatory for growth inhibition and differentiation of human myeloid leukemia cells. , 1993, Leukemia.

[51]  J. León,et al.  Differential expression of ras protooncogenes during in vitro differentiation of human erythroleukemia cells. , 1992, Cancer research.

[52]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[53]  P. Rowley,et al.  Inducers of erythroid differentiation in K562 human leukemia cells. , 1981, Experimental hematology.

[54]  B. B. Mishell,et al.  Selected Methods in Cellular Immunology , 1980 .